Immunovant, Inc. (IMVT)
37.36
-0.74
(-1.94%)
USD |
NASDAQ |
Sep 11, 16:00
37.32
-0.04
(-0.11%)
After-Hours: 20:00
Immunovant Price to Book Value : 10.48 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 10.48 |
| September 10, 2026 | 10.69 |
| September 09, 2026 | 10.87 |
| September 08, 2026 | 11.10 |
| September 04, 2026 | 11.01 |
| September 03, 2026 | 10.97 |
| September 02, 2026 | 11.08 |
| September 01, 2026 | 11.19 |
| August 31, 2026 | 11.45 |
| August 28, 2026 | 11.56 |
| August 27, 2026 | 12.29 |
| August 26, 2026 | 12.31 |
| August 25, 2026 | 12.20 |
| August 24, 2026 | 12.15 |
| August 21, 2026 | 12.45 |
| August 20, 2026 | 12.44 |
| August 19, 2026 | 12.61 |
| August 18, 2026 | 12.43 |
| August 17, 2026 | 12.26 |
| August 14, 2026 | 11.73 |
| August 13, 2026 | 11.73 |
| August 12, 2026 | 11.95 |
| August 11, 2026 | 11.48 |
| August 10, 2026 | 11.19 |
| August 07, 2026 | 11.21 |
| Date | Value |
|---|---|
| August 06, 2026 | 11.15 |
| August 05, 2026 | 11.02 |
| August 04, 2026 | 11.04 |
| August 03, 2026 | 10.80 |
| July 31, 2026 | 10.83 |
| July 30, 2026 | 11.07 |
| July 29, 2026 | 10.83 |
| July 28, 2026 | 10.91 |
| July 27, 2026 | 11.24 |
| July 24, 2026 | 11.05 |
| July 23, 2026 | 11.04 |
| July 22, 2026 | 10.95 |
| July 21, 2026 | 11.09 |
| July 20, 2026 | 11.20 |
| July 17, 2026 | 11.29 |
| July 16, 2026 | 10.93 |
| July 15, 2026 | 11.19 |
| July 14, 2026 | 10.87 |
| July 13, 2026 | 10.85 |
| July 10, 2026 | 11.14 |
| July 09, 2026 | 11.53 |
| July 08, 2026 | 11.31 |
| July 07, 2026 | 11.24 |
| July 06, 2026 | 10.83 |
| July 02, 2026 | 10.88 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Moderna, Inc. | 8.496 |
| Altimmune, Inc. | 1.341 |
| TG Therapeutics, Inc. | 13.66 |
| Dianthus Therapeutics, Inc. | 4.965 |
| First Tracks Biotherapeutics, Inc. | 7.640 |
Price to Book Value Related Metrics
| Price | 37.36 |
| Earnings Yield | -7.52% |
| Market Cap | 7.706B |